Rasagilin Spirig HC 1 mg, Tabletten

7680673620021 CH-67362 Tabletten
Rasagilin Spirig HC 1 mg, Tabletten
Rasagilin Spirig HC 1 mg, Tabletten
Rasagilin Spirig HC 1 mg, Tabletten
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/04/2020
Patient information leaflet
Français
23/04/2020
Patient information leaflet
Italien
23/04/2020
Summary of Product Characteristics
Allemand
23/04/2020
Summary of Product Characteristics
Français
23/04/2020

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
natrium
- Substance HBESI
povidonum K 30
- Substance HNIDK
acidum phosphoricum concentratum
- Substance HNIDK
acidum stearicum
- Substance HNIDK

Reimbursement information

Public price
CHF 194.70
Specialties list
Yes
Generic
Yes
SL addition date: 01/12/2020

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
67362
Drug name
Rasagilin Spirig HC, Tabletten
Galenic form
TAB
ATC Code
N04BD02
Authorization status
Z
Dispensing category
B
First authorization
14/04/2020
Authorization expiration date
31/12/9999
IT Number
01.08.0.
Domain
Human medicine
Field of application
Morbus Parkinson

Package details

Description (FR)
RASAGILINE Spirig HC cpr 1 mg 100 pce
Description (DE)
RASAGILIN Spirig HC Tabl 1 mg 100 Stk
Market launch
14/04/2020
Narcotic (BTM)
No

Original drug

Azilect, Tabletten
GTIN: 7680570650046
CHF 236.75
View original

Other package sizes (1)

RASAGILINE Spirig HC cpr 1 mg 30 pce
30 TABL
GTIN: 7680673620014
View